Medipixel

11/05/2026

🎥 A glimpse into Medipixel at TCTAP 2026 💙

From meaningful conversations with physicians and industry experts to hands-on demonstrations of MPFFR, TCTAP 2026 was an exciting milestone for our team.

This year’s congress marked the official launch of MPFFR, Medipixel’s AI-powered angio-derived FFR solution, and we were excited to see strong interest in its potential to bring fast, one-click physiological assessment into everyday clinical practice — without pressure wires or workflow disruption.

Thank you once again to everyone who visited our booth and shared valuable insights throughout the event.

Here’s a look back at the energy, discussions, and moments that made TCTAP 2026 so meaningful for us ✨

07/05/2026

🚀 MPFFR Successfully Launched at TCTAP 2026 💙

TCTAP 2026 has officially come to a close—and for us at Medipixel, it marked a defining moment.

We proudly unveiled the grand launch of MPFFR, now selected under Korea’s Deferred Health Technology Assessment (DHTA) program.

What stood out most during the congress was the response from physicians across the globe. Seeing firsthand how MPFFR delivers fast, reliable FFR results with a single click, many expressed genuine excitement about its potential to simplify workflow while improving clinical confidence.

This isn’t just about speed or automation—it’s about making coronary physiology more accessible, more consistent, and ultimately more actionable in everyday practice.

Grateful for the conversations, the curiosity, and the momentum we felt throughout the event. We’re just getting started. ✨

20/04/2026

🚀 MPFFR Grand Launch at TCTAP 2026

Medipixel is excited to introduce MPFFR—now officially entering the clinical market following its designation as a new health technology under conditional approval by NECA in Korea.

Experience how AI-powered, angio-derived functional assessment fits seamlessly into routine practice.

👉 Visit us at Booth #30

📅 April 30 – May 2, 2026 (Exhibition period)
📍COEX, Seoul, Korea

✔️ Bring your own DICOM cases for a hands-on experience
✔️ Explore real-world applications of MPFFR
☕ Enjoy coffee & special cookies at our booth

We look forward to welcoming you at TCTAP 2026.

09/04/2026

📈 MPFFR, 임상 적용을 넘어 확산 단계로 진입

메디픽셀의 AI 기반 관상동맥 기능평가 솔루션 MPFFR이 NECA 평가유예 신의료기술로 선정되며 실제 임상 적용이 가능한 환경이 마련되었습니다.

이번 선정의 의미는 단순한 기술 적용을 넘어, 의료기관이 실제 도입을 전제로 검토할 수 있는 기반이 마련되었다는 점에 있습니다.

이는 MPFFR이 검증된 기술 단계를 넘어 실질적인 시장 확산 단계로 진입하고 있음을 보여주는 중요한 전환점입니다.

메디픽셀은 앞으로 임상 근거와 실제 사용 경험을 기반으로 보다 넓은 clinical adoption을 만들어 나가겠습니다.

자세한 내용은 아래 기사에서 확인해 보세요.

🔗 기사 원문 https://www.edaily.co.kr/News/Read?newsId=02013926645413496&mediaCodeNo=257&OutLnkChk=Y

📈 MPFFR enters the next phase: beyond clinical use, toward scalable adoption

Medipixel’s AI-based coronary physiology solution, MPFFR, has been designated as a conditional new health technology by NECA in Korea.

This designation enables its use in real-world clinical settings within the Korean healthcare system, establishing a pathway for healthcare providers to actively evaluate adoption.

In other words, MPFFR is moving from a validated solution to one that is ready for scalable clinical deployment.

Medipixel will continue to expand clinical evidence and real-world usage to support broader adoption in coronary physiology assessment.

🔗 Learn more in the article below
https://www.edaily.co.kr/News/Read?newsId=02013926645413496&mediaCodeNo=257&OutLnkChk=Y

이 기사는 2026년03월27일 08시10분에 팜이데일리 프리미엄 콘텐츠로 선공개 되었습니다. 의료 인공지능(AI) 기업 메디픽셀의 심혈관 AI 분석 솔루션이 마침내 수익을 올릴 방안이 마련됐다.관상동맥 조영영상 기반 기능평가 소프트...

31/03/2026

🏆 We are proud to share that Medipixel has been awarded the Judges’ Choice Winner at the 2026 Innovation Pitch Challenge during in New Orleans. 🇺🇸

Among outstanding cardiovascular start-ups from around the world, it is a true honor to be recognized by such a distinguished panel of clinicians, experts, and investors.

💡 At Medipixel, we presented our vision of a Continuous Intelligence Platform integrating morphological assessment and physiological evaluation to support more precise, data-driven decision-making in coronary interventions.

🔄 We believe the future of cardiovascular care lies beyond isolated measurements toward continuous, integrated intelligence that connects imaging, physiology, and clinical insight in real time.

This recognition is a strong validation of the journey we’ve been on, and more importantly, the direction we are heading.

🙏 A big thank you to the organizers, judges, and everyone who continues to support innovation in cardiovascular care.

🚀 We’re just getting started!

26/03/2026

MPOne: AI-Driven Continuous Intelligence for PCI Decision Making

Medipixel has been selected as a finalist at the Future Hub Innovation Pitch Competition.

At , we will present MPOne, our AI-powered platform designed to support the PCI decision-making process—from image selection to functional assessment.

📍 Ernest N. Morial Convention Center, New Orleans📅 March 28, 2026 | 4:15–5:15 PM
📌 Future Hub (Booth 148) | Session #8005

Join us to see how AI can support more efficient and informed PCI decision-making.

17/03/2026

🚀 메디픽셀 MPFFR, 평가유예 신의료기술 선정

메디픽셀의 AI 기반 관상동맥 기능평가 솔루션 MPFFR이 한국보건의료연구원(NECA) 평가유예 신의료기술로 선정되었습니다.

이번 선정을 통해 실제 의료현장에서 환자에게 비용 청구가 가능해지며, 본격적인 임상 적용 확대의 기반이 마련되었습니다.

심혈관 중재 시술에서 MPFFR의 임상적 의미와 향후 적용 계획에 대한 자세한 내용은 아래 기사에서 확인해 보세요.

🔗 기사 원문: https://www.digitalchosuncnm.com/news/articleView.html?idxno=10227

🚀 A step forward in coronary physiology assessment.

Medipixel’s AI-based coronary physiology solution, MPFFR, has been designated as a conditional new health technology by NECA in Korea.

This designation enables its use in real-world clinical settings with reimbursement, marking an important step toward broader clinical adoption.

For more details on the clinical relevance of MPFFR in interventional cardiology and its future application plans, please refer to the article below.

🔗 Read the full article:
https://www.digitalchosuncnm.com/news/articleView.html?idxno=10227



22/01/2026

At KSIC 2026, Medipixel hosted an interactive MPFFR Learning Center, bringing together clinical case discussions and practical insights into AI-driven Angio-FFR.

During the session, Prof. Joo Myung Lee presented real-world clinical cases demonstrating how MPFFR delivers fully automated vessel contouring and instant FFR results in approximately 10 seconds with minimal manual correction.

In addition, Prof. Seung Hun Lee shared an insightful presentation on common pitfalls in Angio-FFR, addressing real-world limitations related to image quality, vessel anatomy, and contouring variability—offering valuable perspective on when and how Angio-FFR should be applied in daily practice.

Through these discussions, participants were able to explore not only the strengths of AI-powered Angio-FFR, but also the practical considerations required for confident physiological decision-making in routine PCI.

We sincerely thank all clinicians who joined the Learning Center and contributed to thoughtful discussions.

Your engagement continues to drive meaningful progress toward more reliable and practical AI solutions in interventional cardiology. 💙

21/01/2026

At KSIC 2026, Medipixel officially launched MPFFR, our AI-powered Angio-FFR solution designed for routine clinical practice.✨

KSIC 2026 marked an important milestone where clinicians could experience MPFFR firsthand—seeing how AI-driven angiography-derived FFR enables fast, fully automated functional assessment without disrupting existing cath lab workflows.

At our booth, visitors were invited to watch a short MPFFR video demonstration and take part in an interactive quiz, followed by a small giveaway event.

The strong engagement and positive responses from clinicians highlighted a growing interest in practical, AI-enabled solutions that fit seamlessly into daily PCI decision-making.

We sincerely thank everyone who visited our booth and shared their feedback.

We look forward to continuing these meaningful conversations as we advance smarter and more accessible cardiovascular care. 💙

15/01/2026

🚀 Experience "Physiology on Autopilot" at KSIC 2026!
We are thrilled to invite you to an exclusive session hosted by Medipixel during The 22nd KSIC International Conference in Winter. Join us as we explore the future of cardiovascular diagnostics and demonstrate how we are simplifying FFR with our cutting-edge Angio-FFR (MPFFR) technology.


🎤 Program Agenda:
15:00 - 15:05: Introduction to Medipixel Eunsil Kang (CBO, Medipixel)
15:05 - 15:30: MPFFR Overview and Workflow – Joo Myung Lee, M.D. (Samsung Medical Center)
15:30 - 15:40: Common Pitfalls in Angio-FFR – Seung Hun Lee, M.D. (Chonnam National University Hospital)
15:40 - 15:50: MPFFR in Practice: Case Presentation – Joo Myung Lee, M.D.
15:50 - 16:00: Q&A & Live Hands-on Session

📅 Session Details:
Topic: Simplifying FFR with Angio-FFR (MPFFR)
Date: Friday, January 16, 2026
Time: 15:00 - 16:00
Venue: Ruby Room, Yeong Bin Gwan, The Shilla Seoul

📍 Visit Our Booth!
Can't make the session? Come meet the team at Booth #18 located on the 2F of Shilla Hotel Seoul to see our technology in action.

Discover how Medipixel is transforming the landscape of interventional cardiology through AI-driven solutions. We look forward to seeing you soon!